5 min - BioSense Team - 2026-06-24
- level:understanding
- cholestérol
- glycémie
- vitamine d
- prévention
From age 50, certain biological readings become particularly predictive of your health over the next ten to twenty years. They aren't necessarily the most spectacular markers — but they are the ones that, read together and over time, can genuinely change your trajectory. Here are the five priority markers and why they're worth reading as a coherent whole.
You're 55. Your latest blood panel just came back, "everything is within range," and yet your doctor mentioned monitoring for the years ahead. You wonder what really deserves your attention — and why now.
The answer is less technical than people think. At 50, biological readings change in nature: you move from a medicine that reacts to symptoms to a medicine that anticipates risks ten or twenty years out. Five markers, read together, trace that trajectory.
Why reading a blood panel changes at 50
Before 50, a blood test most often serves to explore a complaint (fatigue, a symptom, a clinical suspicion) or to detect a problem early. After 50, its preventive role takes on another dimension: it begins to map out your cardiovascular, metabolic and bone risk for the next twenty to thirty years. This is the period when action is most effective, because it works upstream of serious events (heart attack, stroke, fracture, established diabetes).
A second essential change: risk factors don't add up, they multiply. Having a single borderline marker (for example a slightly elevated LDL) is not the same problem as having three at once. This is precisely what cardiologists call "overall cardiovascular risk," and it explains why your doctor never relies on a single isolated number. A moderate cholesterol combined with borderline blood glucose, borderline blood pressure and a bit of abdominal excess weight is no longer a sum of minor elements — it's what's called metabolic syndrome, a major cardiovascular risk factor.
The third change is temporal. At 50, the actions you take on your lifestyle don't pay off in six months, as they do at 30, but they genuinely change your health at 65, 70, 80. It's a long horizon, which calls for a different reading of the numbers.
Key point — At 50, reading a blood panel changes: you're mapping risk ten to twenty years out, not the situation of the day. Risk factors multiply more than they add up. This is precisely the period when preventive action pays off the most.
The five priority markers after 50
Five markers stand out for their predictive value over the next twenty to thirty years. They don't replace the other tests — they are the priority foundation.
1. The lipid panel: LDL cholesterol above all
This is the best-documented marker for long-term cardiovascular prevention. European guidelines (ESC/EAS 2019, updated in 2025) define different LDL cholesterol targets depending on your overall cardiovascular risk — that is, the combination of your age, sex, smoking, blood pressure, blood glucose, and family history. For a low-risk person, an LDL below 1.16 g/L is the target; for a high-risk person, the goal drops to below 0.70 g/L. At 50, not knowing your overall cardiovascular risk means not knowing which target to aim for.
2. Blood glucose and HbA1c
Type 2 diabetes is silent for years before it reveals itself. HbA1c reflects your average blood glucose over two to three months and helps detect prediabetes (between 5.7% and 6.4%) well before a one-off glucose reading rises clearly. At 50, this is the window where a lifestyle change can prevent progression to diabetes — backed by international studies (DPP, Da Qing). To go further, see HbA1c: the key marker of prediabetes and diabetes.
3. Kidney function: creatinine and estimated GFR
The kidneys decline slowly with age, and chronic kidney disease is underdiagnosed. The glomerular filtration rate (GFR) estimated from creatinine and age gives a good approximation of kidney function. At 50, regular monitoring makes it possible to detect early impairment, particularly in the presence of high blood pressure or diabetes — two major causes of kidney disease.
4. TSH: the thyroid
Thyroid disorders, in particular hypothyroidism, become more common after 50, especially in women. Their symptoms (fatigue, weight gain, feeling cold, slowing down) partly overlap with those of other situations (perimenopause, deconditioning, depression), which makes them easy to miss. A TSH measurement is useful when symptoms are present, and in women over 50 depending on context.
5. Vitamin D
After 50, bone loss accelerates, particularly in post-menopausal women. Vitamin D plays a key role in calcium absorption and bone health. An important reminder: since 2014, the 25-OH vitamin D assay is only reimbursed in France for specific indications (repeated falls, follow-up after bariatric surgery, etc.). Outside these, testing is possible but at your own expense, and supplementation can often be prescribed without prior testing, in line with current guidelines.
Key point — Lipid panel, blood glucose/HbA1c, kidney function, TSH and vitamin D: these five markers form the foundation of preventive monitoring after 50. All are reimbursed on medical prescription, except vitamin D outside specific indications.
Why read these five markers together
Here's what separates a modern reading of a blood panel from a marker-by-marker reading: these five tests trace a cluster. Several moderate abnormalities, taken together, can indicate metabolic syndrome — a state that significantly multiplies cardiovascular risk.
According to the international consensus definition, metabolic syndrome is defined by the presence of at least three criteria among: increased waist circumference (over 94 cm in men, over 80 cm in women according to the European definition), elevated fasting blood glucose (above 1 g/L) or prediabetes, high triglycerides, low HDL, high blood pressure. A person may show each of these "borderline" markers without any single one triggering an alert, and yet accumulate substantial risk.
This is precisely why, at 50, reading your panel "in silos" becomes insufficient. A blood glucose of 1.05 g/L, an LDL of 1.40 g/L, triglycerides at 1.80 g/L and a waist circumference of 96 cm in a 55-year-old man: none of these figures is dramatic taken separately. Together, they constitute a cardiovascular signal that deserves a real discussion with your doctor.
Key point — Several "borderline" markers read together can constitute metabolic syndrome, whose cardiovascular risk is far greater than that of an isolated marker. It's the overall reading that changes the reading.
Adapting monitoring to your profile
Not all profiles are alike at 50. Three elements significantly change how these five markers are read.
First, sex. Men accumulate their cardiovascular risk earlier than women; women see it rise after menopause, when the protective effect of oestrogens fades. The lipid profile, in particular, often shifts in post-menopausal women — which is precisely when regular monitoring makes sense.
Second, family history. A heart attack in a first-degree relative before 55 (men) or 60 (women), a family history of diabetes, early hypertension: these are elements that change the thresholds of vigilance and should lead to tighter monitoring earlier and more often.
Third, lifestyle. Active smoking, a sedentary lifestyle, an unbalanced diet, abdominal excess weight, excessive alcohol consumption: these factors add to (and multiply with) the biological markers. Conversely, regular physical activity, a balanced diet and good-quality sleep can offset part of an unfavourable terrain.
The BioSense method
This overall reading is precisely what BioSense makes accessible. Rather than examining your results marker by marker, BioSense cross-references your five major cardiometabolic markers with your health questionnaire (age, sex, family history, lifestyle, treatments, reason for the prescription) and with official guidelines. Your results are also tracked over time, which is essential for spotting an unfavourable trajectory before it becomes a clinical event.
*ChatGPT answers you. BioSense knows you.* *BioSense, your prevention companion.* BioSense does not provide a diagnosis and does not replace your doctor. It is a prevention companion that helps you understand, ask the right questions and act day to day.
Preparing for your medical appointment: three useful questions
If you're over 50, here are three questions to prepare to steer your next consultation beyond "everything is within range."
- Given my five priority markers (lipids, blood glucose, kidney function, TSH, vitamin D) and my profile, has my overall cardiovascular risk been calculated recently, and where does it stand?
- Are there elements in my panel that, read together, suggest early metabolic syndrome, even if no isolated marker triggers an alert?
- Given my current results and my family history, how often should I repeat these tests, and which lifestyle levers would have the most impact on my trajectory?
Import your blood test into BioSense and receive a plain-language overall reading of your five cardiometabolic markers, contextualised to your personal profile, compared with official guidelines and tracked over time. Your data is hosted in France on infrastructure certified for hosting health data (HDS).
[→ Import my report](/en/onboarding/upload)
Sources and methodology
- European Society of Cardiology and European Atherosclerosis Society (ESC/EAS) — 2019 Guidelines for the management of dyslipidaemias (European Heart Journal, 2019), with a targeted 2025 update: LDL targets according to overall cardiovascular risk.
- ESC — SCORE2 and SCORE2-OP (Older Persons) cardiovascular risk calculation tools, 2021.
- Haute Autorité de Santé (HAS) — Care pathway guide: Type 2 diabetes in adults.
- HAS — Assessment of glomerular filtration rate and chronic kidney disease.
- HAS — Management of hypothyroidism in adults (good-practice recommendation, 2022).
- International Diabetes Federation (IDF) — Worldwide definition of the metabolic syndrome (international consensus).
- American Heart Association (AHA) — Diagnosis and management of the metabolic syndrome (scientific statement).
- UNCAM — Decisions of 14 August 2014 and 25 November 2021 on the reimbursement of vitamin D testing.
- GRIO (Groupe de Recherche et d'Information sur les Ostéoporoses) — Recommendations on vitamin D.
*BioSense methodology: our content draws on official French guidelines (HAS, ANSM, Santé Publique France, INSERM, Assurance Maladie, Anses), European guidelines (ESC, EASD, NICE) and international ones (WHO, ADA, AHA, NIH), as well as specialised learned societies (SFE, SFBC, GRIO). It is reviewed with an educational approach before publication.*
Going further
- Annual blood test after 40: which tests to genuinely request
- Health check-up: what France's social security actually reimburses
- HbA1c: the key marker of prediabetes and diabetes
*This article is for informational purposes only and is neither medical advice nor a diagnosis. For any questions about your health, consult your doctor.*